Unknown

Dataset Information

0

Integrin-mediated type II TGF-? receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.


ABSTRACT: Tubulointerstitial fibrosis underlies all forms of end-stage kidney disease. TGF-? mediates both the development and the progression of kidney fibrosis through binding and activation of the serine/threonine kinase type II TGF-? receptor (T?RII), which in turn promotes a T?RI-mediated SMAD-dependent fibrotic signaling cascade. Autophosphorylation of serine residues within T?RII is considered the principal regulatory mechanism of T?RII-induced signaling; however, there are 5 tyrosine residues within the cytoplasmic tail that could potentially mediate T?RII-dependent SMAD activation. Here, we determined that phosphorylation of tyrosines within the T?RII tail was essential for SMAD-dependent fibrotic signaling within cells of the kidney collecting duct. Conversely, the T cell protein tyrosine phosphatase (TCPTP) dephosphorylated T?RII tail tyrosine residues, resulting in inhibition of T?R-dependent fibrotic signaling. The collagen-binding receptor integrin ?1?1 was required for recruitment of TCPTP to the T?RII tail, as mice lacking this integrin exhibited impaired TCPTP-mediated tyrosine dephosphorylation of T?RII that led to severe fibrosis in a unilateral ureteral obstruction model of renal fibrosis. Together, these findings uncover a crosstalk between integrin ?1?1 and T?RII that is essential for T?RII-mediated SMAD activation and fibrotic signaling pathways.

SUBMITTER: Chen X 

PROVIDER: S-EPMC4109532 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Chen Xiwu X   Wang Hongtao H   Liao Hong-Jun HJ   Hu Wen W   Gewin Leslie L   Mernaugh Glenda G   Zhang Sheng S   Zhang Zhong-Yin ZY   Vega-Montoto Lorenzo L   Vanacore Roberto M RM   Fässler Reinhard R   Zent Roy R   Pozzi Ambra A  

The Journal of clinical investigation 20140701 8


Tubulointerstitial fibrosis underlies all forms of end-stage kidney disease. TGF-β mediates both the development and the progression of kidney fibrosis through binding and activation of the serine/threonine kinase type II TGF-β receptor (TβRII), which in turn promotes a TβRI-mediated SMAD-dependent fibrotic signaling cascade. Autophosphorylation of serine residues within TβRII is considered the principal regulatory mechanism of TβRII-induced signaling; however, there are 5 tyrosine residues with  ...[more]

Similar Datasets

| S-EPMC4954768 | biostudies-literature
| S-EPMC3804746 | biostudies-literature
| S-EPMC4792076 | biostudies-literature
2013-12-16 | E-MTAB-1528 | biostudies-arrayexpress
| S-EPMC6664006 | biostudies-literature
| S-EPMC5509761 | biostudies-other
2016-08-18 | E-MTAB-4810 | biostudies-arrayexpress
| S-EPMC7238552 | biostudies-literature
| S-EPMC4560490 | biostudies-literature
| S-EPMC3000994 | biostudies-literature